Nicholas Pavlidis
About
In The Last Decade
Nicholas Pavlidis
319 papers receiving 12.7k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Oncology 8.7k
- Pathology and Forensic Medicine 3.0k
- Pulmonary and Respiratory Medicine 2.4k
- Molecular Biology 2.3k
- Oral Surgery 1.8k
Countries citing papers authored by Nicholas Pavlidis
This map shows the geographic impact of Nicholas Pavlidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Pavlidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Pavlidis more than expected).
Fields of papers citing papers by Nicholas Pavlidis
This network shows the impact of papers produced by Nicholas Pavlidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Pavlidis. The network helps show where Nicholas Pavlidis may publish in the future.
Co-authorship network of co-authors of Nicholas Pavlidis
This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Pavlidis. A scholar is included among the top collaborators of Nicholas Pavlidis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Pavlidis. Nicholas Pavlidis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Prognostic factors in glioblastoma patients managed with radiotherapy combined with temozolomide. | 3 |
| 2 | 4 | |
| 3 | 62 | |
| 4 | 20 | |
| 5 | 77 | |
| 6 | 55 | |
| 7 | Treatment of colorectal cancer in the elderly: a review of the literature | 2 |
| 8 | Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data. | 43 |
| 9 | 22 | |
| 10 | 186 | |
| 11 | 1 | |
| 12 | 24 | |
| 13 | Clear cell ovarian carcinoma in a pregnant woman with a history of infertility, endometriosis and unsuccessful IVF treatment. | 11 |
| 14 | 61 | |
| 15 | Bcl2 and p53 protein expression in metastatic carcinoma of unknown primary origin: biological and clinical implications. A Hellenic Co-operative Oncology Group study. | 44 |
| 16 | Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary origin. | 47 |
| 17 | 32 | |
| 18 | 44 | |
| 19 | Role of E-type prostaglandins in the regulation of interferon-treated macrophage cytotoxic activity. | 21 |
| 20 | Effect of maleic anhydride-divinyl ether copolymers on experimental M109 metastases and macrophage tumoricidal function. | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.